Event Type
Disclosure
Voluntary
Variant
8-K
(including Exhibit 99.1) shall not be deemed to be “filed” for purposes of, or otherwise subject to the liabilities of, Section 18 of the Exchange Act, nor shal
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 vTv Therapeutics' Investor Presentation dated February 202 6 104 Cover Page Interact